Posts by David H. Jung, MD, PhD
-
Novel Conjugated Molecule Shows Preclinical Potential to Treat Sensorineural Hearing Loss
Researchers at Mass Eye and Ear are part of the first team to establish that a small-molecule analog of neurotrophin-3 can promote inner ear neurite outgrowth and synaptogenesis in vitro, findings that have important implications for treatment of sensorineural hearing loss.
Biography
Specializing in the treatment of ear disorders, Dr. David Jung has a particular clinical interest in skull base disorders, including superior canal dehiscence and tumors, such as vestibular schwannomas. His clinical practice also encompasses surgery for chronic ear disease, conductive hearing loss including stapedectomy and bone-anchored hearing aid placement, and cochlear implantation for severe sensorineural hearing loss.
Dr. Jung's current research focuses on the development of novel methods for cochlear drug delivery and understanding mechanisms of noise- and age-related hearing loss.
Mass Eye and Ear/Mass General Otolaryngology–Head and Neck Surgery
A teaching hospital of Harvard Medical School, Mass Eye and Ear/Massachusetts General Hospital combines the expertise of highly specialized ear, nose, and throat physicians, audiologists, speech-language pathologists and auxiliary health care professionals to provide care for patients with problems affecting the ear, nose, throat, head and neck areas. The department, which is led by Chief and Chair Mark A. Varvares, MD, FACS, is one of the largest otolaryngology–head and neck surgery (OHNS) departments in the country, with more than 70 physicians staffed at 15 locations in the greater Boston area.
